<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>ArriVent BioPharma, Inc. (AVBP) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/avbp/filings</link>
    <description>Latest company filings for ArriVent BioPharma, Inc. (AVBP) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 07:42:30 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/avbp/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926058706/tm2614177d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-26-058706</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926058700/tm2614155-1_424b5.htm</link>
      <guid isPermaLink="false">0001104659-26-058700</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Prospectus supplement (424B5) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926058650/avbp-20260331x10q.htm</link>
      <guid isPermaLink="false">0001104659-26-058650</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Quarterly report (10-Q) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926058638/avbp-20260511x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-058638</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000031506626001106/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000315066-26-001106</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926050350/tm263534d1_ars.pdf</link>
      <guid isPermaLink="false">0001104659-26-050350</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Annual report to shareholders (ARS) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926050344/tm261626d3_defa14a.htm</link>
      <guid isPermaLink="false">0001104659-26-050344</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Proxy materials (DEFA14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926050337/tm261626-1_def14a.htm</link>
      <guid isPermaLink="false">0001104659-26-050337</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Proxy statement (DEF 14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926029588/avbp-20260317x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-029588</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926024136/tm267878d1_s8.htm</link>
      <guid isPermaLink="false">0001104659-26-024136</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Employee stock plan (S-8) on 2026-03-05.]]></description>
      <pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926024127/avbp-20251231x10k.htm</link>
      <guid isPermaLink="false">0001104659-26-024127</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Annual report (10-K) on 2026-03-05.]]></description>
      <pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926024112/avbp-20260305x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-024112</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2026-03-05.]]></description>
      <pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926023750/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-023750</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-05.]]></description>
      <pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000205809326000004/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002058093-26-000004</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000090266426001013/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-001013</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926010478/xslF345X05/tm265104-5_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-010478</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926010477/xslF345X05/tm265104-3_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-010477</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926010473/xslF345X05/tm265104-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-010473</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926010472/xslF345X05/tm265104-4_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-010472</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465926010471/xslF345X05/tm265104-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-010471</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000090266426000675/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0000902664-26-000675</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000010290926000090/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000090</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-30.]]></description>
      <pubDate>Fri, 30 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000201238326000643/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002012383-26-000643</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000121465925016716/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001214659-25-016716</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-11-14.]]></description>
      <pubDate>Fri, 14 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925108847/avbp-20250930x10q.htm</link>
      <guid isPermaLink="false">0001104659-25-108847</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Quarterly report (10-Q) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925108839/avbp-20251110x8k.htm</link>
      <guid isPermaLink="false">0001104659-25-108839</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000031506625002677/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000315066-25-002677</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-11-05.]]></description>
      <pubDate>Wed, 05 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000010290925000025/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-25-000025</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-10-30.]]></description>
      <pubDate>Thu, 30 Oct 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000201238325002500/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002012383-25-002500</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-10-17.]]></description>
      <pubDate>Fri, 17 Oct 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925099728/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-25-099728</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-10-15.]]></description>
      <pubDate>Wed, 15 Oct 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000155837025011954/avbp-20250909x8k.htm</link>
      <guid isPermaLink="false">0001558370-25-011954</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2025-09-09.]]></description>
      <pubDate>Tue, 09 Sep 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000141588925021943/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001415889-25-021943</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-08-14.]]></description>
      <pubDate>Thu, 14 Aug 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000205809325000008/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002058093-25-000008</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-08-13.]]></description>
      <pubDate>Wed, 13 Aug 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000094787125000764/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000947871-25-000764</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2025-08-13.]]></description>
      <pubDate>Wed, 13 Aug 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000091957425004712/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000919574-25-004712</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-08-13.]]></description>
      <pubDate>Wed, 13 Aug 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000155837025010975/avbp-20250630x10q.htm</link>
      <guid isPermaLink="false">0001558370-25-010975</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Quarterly report (10-Q) on 2025-08-11.]]></description>
      <pubDate>Mon, 11 Aug 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000155837025010974/avbp-20250811x8k.htm</link>
      <guid isPermaLink="false">0001558370-25-010974</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2025-08-11.]]></description>
      <pubDate>Mon, 11 Aug 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925069169/tm2521271d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-25-069169</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2025-07-21.]]></description>
      <pubDate>Mon, 21 Jul 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925067928/xslF345X05/tm2520948-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-067928</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2025-07-15.]]></description>
      <pubDate>Tue, 15 Jul 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925065391/tm2519401-2_424b5.htm</link>
      <guid isPermaLink="false">0001104659-25-065391</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Prospectus supplement (424B5) on 2025-07-02.]]></description>
      <pubDate>Wed, 02 Jul 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925065386/tm2519401d3_8k.htm</link>
      <guid isPermaLink="false">0001104659-25-065386</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2025-07-02.]]></description>
      <pubDate>Wed, 02 Jul 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925064736/tm2519401-1_424b5.htm</link>
      <guid isPermaLink="false">0001104659-25-064736</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Prospectus supplement (424B5) on 2025-07-01.]]></description>
      <pubDate>Tue, 01 Jul 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925061375/tm2518615d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-25-061375</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2025-06-23.]]></description>
      <pubDate>Mon, 23 Jun 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925061270/xslF345X05/tm2518583-4_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-061270</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2025-06-20.]]></description>
      <pubDate>Fri, 20 Jun 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925061269/xslF345X05/tm2518583-3_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-061269</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2025-06-20.]]></description>
      <pubDate>Fri, 20 Jun 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925061268/xslF345X05/tm2518583-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-061268</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2025-06-20.]]></description>
      <pubDate>Fri, 20 Jun 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925061267/xslF345X05/tm2518583-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-061267</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Insider trade (4) on 2025-06-20.]]></description>
      <pubDate>Fri, 20 Jun 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000110465925061165/tm2518556d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-25-061165</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Major company event (8-K) on 2025-06-20.]]></description>
      <pubDate>Fri, 20 Jun 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVBP: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000205809325000002/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002058093-25-000002</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-05-15.]]></description>
      <pubDate>Thu, 15 May 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AVBP: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1868279/000155837025007276/avbp-20250331x10q.htm</link>
      <guid isPermaLink="false">0001558370-25-007276</guid>
      <description><![CDATA[ArriVent BioPharma, Inc. filed a Quarterly report (10-Q) on 2025-05-12.]]></description>
      <pubDate>Mon, 12 May 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
  </channel>
</rss>